What is Monarch PCM?
Monarch PCM provides comprehensive pharmaceutical serialization services, ensuring full compliance with the Drug Supply Chain Security Act (DSCSA) of 2013. The company's solutions enhance transparency and visibility within the supply chain, aiding clients in reducing theft, diversion, and counterfeiting. Furthermore, Monarch PCM's services improve shipping accuracy and streamline the process for removing recalled or defective products, positioning it as a critical partner for pharmaceutical manufacturers and distributors navigating complex regulatory landscapes.
How much funding has Monarch PCM raised?
Monarch PCM has raised a total of $1.2M across 2 funding rounds:
Debt
$350K
Debt
$842K
Debt (2020): $350K with participation from PPP
Debt (2021): $842K led by PPP
Key Investors in Monarch PCM
PPP
Public-Private Partnership
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Monarch PCM?
The substantial enterprise-level funding indicates Monarch PCM is poised for significant scaling and further development of its track and trace capabilities. This strategic investment will likely fuel expansion into new markets, enhance technological infrastructure, and potentially broaden its service offerings to address evolving regulatory demands and industry challenges. The company's focus on DSCSA compliance positions it for continued growth as regulatory enforcement intensifies.
See full Monarch PCM company page
